Table 1.

mRNA expression of Itgam, Emr1, and Tnfα from progression study

	Itgam				Emr1				Tnfα
	CSAA	CDAA	CDAA +1%chol	CDAA +2%chol	CSAA	CDAA	CDAA +1%chol	CDAA +2%chol	CSAA	CDAA	CDAA +1%chol	CDAA +2%chol
4 weeks	1.0 ± 0.2	17.4 ± 2.5	19.0 ± 2.8#	22.9 ± 3.5#	1.0 ± 0.1	3.1 ± 0.5#	4.1 ± 0.5#	3.9 ± 0.4#	1.0 ± 0.1	4.6 ± 0.8#	5.5 ± 0.9#	5.3 ± 0.6#
8 weeks	0.9 ± 0.2	15.0 ± 2.7	43.2 ± 5.4#*∆	36.0 ± 3.6#*	0.7 ± 0.1	2.7 ± 0.4#	4.6 ± 0.3#*	4.8 ± 0.4#*	0.6 ± 0.2	3.5 ± 0.5#	7.7 ± 0.6#*	8.1 ± 0.6#*
12 weeks	1.7 ± 0.2	34.1 ± 4.7#∆$	45.2 ± 5.3#∆	52.3 ± 4.3#*∆	1.3 ± 0.1	3.3 ± 0.4#	3.9 ± 0.3#	4.8 ± 0.2#	1.4 ± 0.4	7.9 ± 0.8#$	9.9 ± 1.0#∆	9.9 ± 0.7#∆

	Acta2				Pai1				Ctgf
	CSAA	CDAA	CDAA +1%chol	CDAA +2%chol	CSAA	CDAA	CDAA +1%chol	CDAA +2%chol	CSAA	CDAA	CDAA +1%chol	CDAA +2%chol
4 weeks	1.0 ± 0.1	10.2 ± 1.4#	10.2 ± 1.5#	12.4 ± 1.2#	1.0 ± 0.3	11.7 ± 2.4	15.9 ± 2.9	20.6 ± 2.6	1.0 ± 0.2	9.8 ± 1.6	21.6 ± 3.6	27.8 ± 3.3#
8 weeks	0.8 ± 0.2	7.9 ± 1.3	16.7 ± 1.9#*	20.3 ± 3.0#*	1.1 ± 0.4	10.3 ± 2.2	32.4 ± 6.4#	36.2 ± 5.3#	1.7 ± 0.6	16.1 ± 3.6	47.1 ± 7.7#*∆	51.1 ± 5.8#*∆
12 weeks	1.6 ± 0.2	20.0 ± 2.9#∆$	19.5 ± 1.9#∆	20.1 ± 2.4#	1.7 ± 0.7	32.9 ± 4.2#	55.0 ± 14.4#∆	59.5 ± 13.0#∆	2.4 ± 0.4	58.3 ± 5.4#∆$	82.3 ± 6.3#*∆$	67.4 ± 7.6#∆

^#P < 0.05 versus CSAA, *P < 0.05 versus CDAA, ^∆P < 0.05 versus same diet at 4 weeks, ^$P < 0.05 versus same diet at 8 weeks